Program Helps Enhance Pharmacist Knowledge of Real-World Evidence
Researchers developed a novel real-world evidence (RWE)
training program for pharmaceutical company field medical professionals to build
competency in RWE research concepts and found...
Digital Therapeutic Helps Treat Opioid Use Disorder with Minimal Budget Impact
reSET-O is the first FDA-approved prescription digital
therapeutic for the treatment of patients with opioid use disorder in combination
with usual treatment (e.g., buprenorphine)....
Incorporating Digital Therapeutics into Utilization Management Practices
Utilization management practices play an important role
in optimizing and driving utilization patterns toward clinically- and
cost-effective products, but the application of inappropriate exclusions can
negatively...
How Digital Therapeutics Can Optimize Care for Various Conditions
Digital therapeutics are emerging as a novel treatment
modality for a wide range of health conditions, either alone or in conjunction
with other treatments....